Clinical Trials Directory

Trials / Completed

CompletedNCT01407965

Pharmacokinetics of Carbapenem Antibiotics in Obese Patients.

Offene, Monozentrische, Nicht Kontrollierte Und Nicht Randomisierte Phase IV-Studie Zur Bestimmung Der Pharmakokinetik Von Carbapenemen in adipösen Patienten.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
13 (actual)
Sponsor
University of Ulm · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Tissue kinetics of ertapenem and meropenem in fatty tissue, intraperitoneal fluid and plasma.

Detailed description

The purpose of this study is to determine the free tissue kinetics of ertapenem and meropenem in fatty tissue and intraperitoneal fluid up to 24 hours after administration of the IMP.

Conditions

Interventions

TypeNameDescription
PROCEDUREmicrodialysis catheterPlacing of microdialysis catheter in fatty tissue and in the peritoneal cavity
PROCEDUREmicrodialysis catheterPlacing of microdialysis catheter in fatty tissue and in the peritoneal cavity

Timeline

Start date
2012-04-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2011-08-02
Last updated
2016-10-17

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01407965. Inclusion in this directory is not an endorsement.

Pharmacokinetics of Carbapenem Antibiotics in Obese Patients. (NCT01407965) · Clinical Trials Directory